prescription medicine Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients. Heart failure affects ...

People with mildly reduced ejection fraction, a distinct group with unique needs, account for nearly one-quarter of HF cases.

When the sympathetic nervous system is unregulated, it can lead to high blood pressure and elevated heart rate. The combination of sacubitril-valsartan, sold as Entresto, that is currently the only ...

Please provide your email address to receive an email when new articles are posted on . The benefits of empagliflozin compared with placebo for HF with reduced ejection fraction occurred regardless of ...

Please provide your email address to receive an email when new articles are posted on . Eplerenone was beneficial to patients regardless of how long they have had heart failure with reduced ejection ...

CLEVELAND -- Whether vagal nerve stimulation improved outcomes for heart failure patients with reduced ejection fraction (HFrEF) remained unclear after ANTHEM-HFrEF was terminated early, with the ...

Swedish investigators looked at potassium levels and all-cause mortality in HFrEF patients at 30 days, 12 months, and 5 years. Over all 3 time frames, the sweet spot in terms of lowest hazard risk for ...

Automatic positive airway pressure was found to significantly improve peak oxygen uptake, left ventricular function, and quality of life in patients with comorbid obstructive sleep apnea and heart ...

Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...

Nine out of 10 hospitalized patients who have heart failure with reduced ejection fraction (HFrEF) may be potential candidates for the novel agent vericiguat (Merck Sharp & Dohme/Bayer) to lower their ...

Only 21.2% of US veterans with newly diagnosed heart failure with reduced ejection fraction (HFrEF) received all four drug classes of guideline-directed medical therapy (GDMT) over a median follow-up ...

prescription medicine Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients. Heart failure affects ...